Common Stock SEC Reporting - Delinquent
OTC Pink Limited Information
Contact Info
  • 11750 Sorrento Valley Rd.
  • Suite 250
  • San Diego, CA 92121

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2015 10-Q
CIK 0000772320
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Business Status Development Stage Company a/o Dec 31, 2011
Incorporated In: DE, USA
Year of Inc. 2003
Employees 15 a/o Dec 31, 2011
Company Officers/Contacts
Christopher Reinhard President, CEO
Tracy Kent Business Affairs, Executive Director
Mira Habel Corporate Controller
Bonnie Ortega IR
Company Directors
Christopher Reinhard Chairman
Company Notes
  • Formerly=Cardium Therapeutics, Inc. until 10-2014
  • Formerly=Aries Ventures, Inc. until 1-06. State of Incorporation Nevada changed to Delaware concurrent with name change
  • Note=5-00 State of Incorporation Colorado changed to Nevada concurrent with name change
  • Formerly=Casmyn Corp. until 5-00
  • Formerly=Summa Metals Corp. until 10-94
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Sheppard, Mullin, Richter & Hampton LLP
12275 El Camino Real
Suite 200
San Diego, CA, 92130
United States

Investor Relations Firm
Mission Investor Relations
3645 Marketplace Blvd.
Suite 130-280
Atlanta, GA, 30344
United States

CRXM Security Details
Share Structure
Market Value1 $2,427,258 a/o Oct 21, 2016
Authorized Shares 200,000,000 a/o Sep 30, 2013
Outstanding Shares 12,775,044 a/o Jun 18, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.0001
Shareholders of Record Not Available
Short Selling Data
Short Interest 42,056 (952.19%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security